Fate Therapeutics
FATE
#7765
Rank
NZ$0.40 B
Marketcap
$3.54
Share price
-6.76%
Change (1 day)
-12.43%
Change (1 year)

P/S ratio for Fate Therapeutics (FATE)

P/S ratio as of November 2024 (TTM): 19.1

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.5939. At the end of 2024 the company had a P/S ratio of 30.3.

P/S ratio history for Fate Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202430.3422.25%
20235.80-42.99%
202210.2-89.82%
2021100-60.36%
202025281.87%
2019139-20.75%
2018175123.55%
201778.3231.94%
201623.6-40.72%
201539.8
2014N/A-100%
2013132

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
7.01-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
3.29-82.83%๐Ÿ‡บ๐Ÿ‡ธ USA
3.67-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA
479 2,402.90%๐Ÿ‡บ๐Ÿ‡ธ USA
5.64-70.52%๐Ÿ‡บ๐Ÿ‡ธ USA